Oct 31, 2006 by Brian GormanKendle's New RiskThe drug development services company continues to deliver, but new debt poses some risk to future earnings.
Oct 30, 2006 by Brian GormanQuality in CovanceSome investors are pulling back from the company's stock, but Covance will continue to deliver.
Oct 24, 2006 by Brian GormanMedco's Fringe BenefitsRecent developments will present some challenges, but Medco remains a solid long-term investment.
Oct 17, 2006 by Brian GormanPPD Disappoints? Not QuiteIts discovery sciences business hindered results, but PPD remains a winner.
Oct 16, 2006 by Brian GormanOshkosh Snags JLGOshkosh's purchase of JLG should help it keep firing on all cylinders.
Oct 9, 2006 by Brian GormanCeladon's Smart MovesThe trucking firm's savvy strategies will make this a long-term winner.
Oct 3, 2006 by Brian GormanBritain's Psychiatric Stir-UpThe U.S. government may be forced to follow Great Britain's example, given recent developments in Medicare.
Oct 2, 2006 by Brian GormanGilead's Smart RiskThe company's latest purchase is a risk, but it's a well-calculated one.
Sep 25, 2006 by Brian GormanHonda Delivers Diesel?A new diesel engine, if affordable, could allow Honda to lap its rivals.
Sep 19, 2006 by Brian GormanDaimler's Bump in the RoadA swift response to problems should speed the automaker's recovery.
Sep 18, 2006 by Brian GormanYahoo! Caught Up in the Past?Its new ad campaign may not be focused on the right people.
Sep 13, 2006 by Brian GormanWill Campbell Get Hotter?Fourth-quarter results were bland, but consumers may be warming up to a new line of soups.
Sep 5, 2006 by Brian GormanBayer Rising?Bayer still has some hoops to jump through before it's in tip-top shape, but the company has some tantalizing opportunities.
Aug 30, 2006 by Brian GormanMylan's Biogeneric PlayThe generic drugmaker buys an Indian firm to strengthen its long-term prospects.
Aug 30, 2006 by Brian GormanAn Integrated India Strategy From EADSPlans to outspend Boeing in India could mean more commercial and defense business in the country.
Aug 28, 2006 by Brian GormanAn Odd Buy for New York TimesThe latest acquisition seems to be neither a great strategic fit nor a particularly good deal.
Aug 25, 2006 by Brian GormanCalifornia's Drug DemandsChanges resulting from the state's drug plan should benefit bigger outsourcers.
Aug 24, 2006 by Brian GormanCBS Plays on RaceCBS's decision to focus on race seems unlikely to capture lasting gains.
Aug 23, 2006 by Brian GormanFord's Latest Wrong TurnThe decision to pull back on hybrids represents a serious blunder.
Aug 17, 2006 by Brian GormanLockheed's Good OffenseA proposal for a JSF drone shows the company is well positioned to capture future defense contracts.
